Chocolate,laagvlieger.x24hr.com,/hissingly327255.html,CDs Vinyl , Dance Electronic , Drum Bass,Album,Wheelchair,$13 Chocolate,laagvlieger.x24hr.com,/hissingly327255.html,CDs Vinyl , Dance Electronic , Drum Bass,Album,Wheelchair,$13 $13 Chocolate Wheelchair Album CDs Vinyl Dance Electronic Drum Bass Chocolate Wheelchair Album Super intense SALE $13 Chocolate Wheelchair Album CDs Vinyl Dance Electronic Drum Bass Chocolate Wheelchair Album Super intense SALE
Chocolate Wheelchair Album
Chocolate Wheelchair Album
Venetian Snares, aka Aaron Funk, continues his successful run on Planet with The Chocolate Wheelchair Album, this time around capturing the spirit of ecstatic jazz in an electronic context. John Coltrane probably couldn't conceive of the music that Funk has created here, but 'Trane's last works (Interstellar Space, particularly) mirror the everything-happening-all-the-time atmosphere of this album. The beats seem to ram through at their own pace, sometimes slowing, sometimes speeding, not really adhering to a straight tempo, but constantly around or above 150 bpms. Individual tracks blur together in a chaos of blastbeats and sampled vocals, making this more of a suite than a collection of tracks. Similar in its unpredictability to the rest of Funk's discography, Chocolate Wheelchair distinguishes itself with the tracks featuring vocal samples, like the ridiculous "Einstein-Rosen Bridge," which manages to sound like a rave track from early-'90s Berlin but somehow disco-fied. The M tley Cr e samples on "Too Young" may be the foundation of today's mash-up scene. The case could be made. But Funk stands outside of the narrowly defined genres of drill'n'bass or hardcore, and laughs infectiously. Besides being intensely danceable, if nothing else, Funk's music is funny as hell. He's the Rashied Ali of sampling and sequencing, and this is his New Directions in Modern Music. This is one of the better albums in the sizable Snares discography. ~ James Mason, Rovi
The Dementia UK Ecosystem (DUKE) brings together leaders from the UK DRI, Dementias Platform UK, the National Institute for Health Research, the pharmaceutical industry, and funders to create a cohesive community, coordinating efforts to accelerate progress in tackling dementia.
Produced by a cross-party group of MPs and Peers in collaboration with Alzheimer’s Society, the 'Fuelling the Moonshot' report is the culmination of a detailed inquiry run by the All-Party Parliamentary Group (APPG) on Dementia, which received evidence from experts and organisations in the field of dementia research. The report makes a case for how the Government’s promised ‘Dementia Moonshot’ funding should be spent to best support research into dementia and neurodegeneration.
Prof Sir David Klenerman, UK DRI Group Leader at Cambridge, and Prof Sir Shankar Balasubramanian have been awarded the 2022 Breakthrough Prize for their development of Next Generation Sequencing. The groundbreaking technology significantly reduced the time and cost associated with sequencing a human genome, revolutionising modern research and medicine.
We accelerate, innovate, deepen and broaden discovery science in dementia, with the goal of filling the huge knowledge gap in this field. We exist to bring forward the day when research benefits people living with and those at risk of dementia.
We have a clearly defined vision at the UK DRI to develop effective therapeutics, diagnostics and technologies for people living with dementia. Alongside building our disease knowledge over the coming years, we will also make progress in translating these discoveries into the clinic.
We study a range of neurodegenerative disorders that cause dementia. Many of them share fundamental disease mechanisms and characteristics, and greater understanding gained in one can often benefit others. To ensure we capitalise on diverse expertise, approaches and perspectives, we have established cross-centre themes.
Our efforts to increase the diversity of our team, ensure inclusion and promote equality of opportunity, align with our vision for the UK DRI’s Institute culture and identity as a world-leader in dementia research.